Wei Liu

Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II–IIIA (N1–N2) EGFR-mutant NSCLC (ADJUVANT/CTONG1104): a randomised, open-label, phase 3 study

Wen‐Zhao Zhong, Qun Wang, Weimin Mao et al. · The Lancet Oncology · 2017 · 520 citations

Medicine, Pathology, Gefitinib Versus Vinorelbine +8

Prognostic factors for the recurrence of sporadic desmoid-type fibromatosis after macroscopically complete resection: Analysis of 114 patients at a single institution

Xiaodong He, Y.B. Zhang, L. Wang et al. · European Journal of Surgical Oncology · 2015 · 39 citations

Prognostic Factors, Fibrosis, Surgical Pathology +5

Efficacy and safety of embolization in iatrogenic traumatic uterine vascular malformations

Z. Wang, Jianwei Chen, HongYu Shi et al. · Clinical Radiology · 2012 · 36 citations

Postpartum Hemorrhage, Endovascular Technique, Vascular Malformation +5

Hesperidin administration suppresses the proliferation of lung cancer cells by promoting apoptosis via targeting the miR‑132/ZEB2 signalling pathway

Song Tan, Lingling Dai, Pengcheng Tan et al. · International Journal of Molecular Medicine · 2020 · 35 citations · Full text

Mir‑132 Mimic, Lung Inflammation, Cell Death +21

A novel large fragment deletion in PLS3 causes rare X-linked early-onset osteoporosis and response to zoledronic acid

Fang Lv, Wei Liu, Xin‐Jian Xu et al. · Osteoporosis International · 2017 · 31 citations

Bone Disease, Bone Health, Orthopaedic Surgery +8